Net Income

With defense spending hitting $2.6T, a new arms race in Edge AI is on. Discover how specialized tech is enabling autonomous warfare and reshaping conflict.

Burford Capital's leadership invests millions from their own pay, claiming shares are deeply discounted. But will the market agree with their bold move?

Michigan-based ELGA CU completes its cross-state purchase of Marine Bank, blending community focus with expanded commercial and consumer services.

A novel stent designed specifically for the brain's veins shows immediate success in its first human tests, offering new hope for a debilitating condition.

A new, highly selective drug for Duchenne muscular dystrophy shows potential to be safer and more effective, targeting both muscle and heart decline.

While national graduate employment dips, SMU's Class of 2025 secures higher salaries and job rates. Their secret lies in mandatory internships and AI fluency.

As electroCore preps its 2025 financial report, all eyes are on its product growth, the new Quell device, and its path to profitability in the booming bioelectronic market.

As firms race to adopt AI, Gartner names BigID a Challenger for its unified platform that tackles the critical challenges of data and AI governance.

National Bank's integration of CWB Wealth sparks fund terminations and a major shift in strategy, forcing investors to make critical financial decisions.

As Capricor prepares its Q4 earnings call, all eyes are on its DMD drug Deramiocel's FDA path, financial health, and next-gen exosome technology.

Thorne released impressive consumer data for its supplements. But what do these studies really mean for consumers in a crowded, unregulated market?

The fintech pioneer just launched an AI-powered advisor. Here's how it plans to change the way you manage money and reshape the entire industry.

AI infrastructure firm GoodVision AI merges with Calisa Acquisition Corp to go public, aiming to solve the critical AI inference challenge with new capital.

Medicus Pharma's microneedle patch for basal cell carcinoma clears nearly three-quarters of lesions, offering a potential non-surgical alternative to the scalpel.

The travel giant reports a $245M profit swing and doubles its share buyback, fueled by its CWT merger and a bold new AI-driven strategy for 2026.

A new surgical robot from Beijing's Healinno Tech uses AI and a high-pressure waterjet to treat prostate issues with unprecedented precision and safety.

With new data on CUE-401, a novel therapy inspired by Nobel-winning science, Cue Biopharma makes a high-stakes play to redefine autoimmune treatment.

As owners demand healthier options, Solid Gold's national launch at Petco reveals the lucrative trend of personalizing pet nutrition.

Founded by Emma Heming Willis, Make Time Wellness unveils three new products, tapping into a booming market with science-backed solutions for women's brain health.

Facing volatile markets, AVAX One pushes for regulatory clarity at the DC Blockchain Summit, aiming to legitimize Avalanche for institutional investors.